Ceridian HCM Holding Inc. (NYSE:CDAY – Get Free Report) has received an average rating of “Moderate Buy” from the fifteen research firms that are currently covering the stock, Marketbeat Ratings reports. Seven investment analysts have rated the stock with a hold recommendation and eight have assigned a buy recommendation to the company. The average 1-year price objective among analysts that have covered the stock in the last year is $79.06.
A number of analysts have recently commented on the company. The Goldman Sachs Group assumed coverage on Ceridian HCM in a research note on Monday, October 23rd. They issued a “neutral” rating and a $74.00 price objective on the stock. Citigroup boosted their price objective on Ceridian HCM from $74.00 to $84.00 and gave the stock a “buy” rating in a research note on Friday, July 21st. UBS Group began coverage on Ceridian HCM in a research report on Tuesday, November 7th. They issued a “buy” rating and a $87.00 price target for the company. Needham & Company LLC restated a “buy” rating and set a $82.00 price objective on shares of Ceridian HCM in a report on Thursday, November 2nd. Finally, Piper Sandler reiterated a “neutral” rating and issued a $73.00 target price on shares of Ceridian HCM in a report on Thursday, October 12th.
Insider Buying and Selling at Ceridian HCM
Institutional Inflows and Outflows
Several institutional investors have recently bought and sold shares of the company. Vanguard Group Inc. raised its holdings in Ceridian HCM by 0.8% in the 1st quarter. Vanguard Group Inc. now owns 15,174,664 shares of the company’s stock worth $1,037,341,000 after acquiring an additional 115,168 shares during the period. Capital International Investors increased its holdings in shares of Ceridian HCM by 29.8% during the 2nd quarter. Capital International Investors now owns 11,453,158 shares of the company’s stock worth $767,013,000 after purchasing an additional 2,632,753 shares during the period. Capital World Investors increased its holdings in shares of Ceridian HCM by 5.5% during the 2nd quarter. Capital World Investors now owns 5,738,988 shares of the company’s stock worth $384,340,000 after purchasing an additional 300,199 shares during the period. Artisan Partners Limited Partnership increased its holdings in shares of Ceridian HCM by 8.9% during the 3rd quarter. Artisan Partners Limited Partnership now owns 3,924,755 shares of the company’s stock worth $266,295,000 after purchasing an additional 321,396 shares during the period. Finally, Bamco Inc. NY increased its holdings in shares of Ceridian HCM by 0.7% during the 3rd quarter. Bamco Inc. NY now owns 3,534,834 shares of the company’s stock worth $239,838,000 after purchasing an additional 23,252 shares during the period.
Ceridian HCM Stock Up 3.0 %
CDAY opened at $69.29 on Friday. Ceridian HCM has a one year low of $55.62 and a one year high of $79.66. The company has a debt-to-equity ratio of 0.53, a quick ratio of 1.10 and a current ratio of 1.09. The stock’s fifty day moving average is $68.87 and its 200-day moving average is $67.63. The company has a market capitalization of $10.82 billion, a PE ratio of 2,310.44, a P/E/G ratio of 3.15 and a beta of 1.43.
Ceridian HCM Company Profile
Ceridian HCM Holding Inc, together with its subsidiaries, operates as a human capital management (HCM) software company in the United States, Canada, and internationally. It offers Dayforce, a cloud HCM platform that provides human resources, payroll, benefits, workforce management, and talent management functionality; and Powerpay, a cloud HR and payroll solution for the small business market.
- Five stocks we like better than Ceridian HCM
- Why Invest in 5G? How to Invest in 5G Stocks
- 3 large caps with red hot RSIs with upside
- Find and Profitably Trade Stocks at 52-Week Lows
- Johnson Controls International: Nothing but upside for investors
- What is the S&P/TSX Index?
- Unity Software’s resilient rebound post-earnings setback
Receive News & Ratings for Ceridian HCM Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ceridian HCM and related companies with MarketBeat.com's FREE daily email newsletter.